Phage therapeutic delivery methods and clinical trials for combating clinically relevant pathogens

Area of Science:

• Microbiology
• Infectious Diseases
• Biotechnology

Background:

• The rise of multidrug-resistant (MDR) bacteria presents a critical global health challenge.
• Existing antimicrobial agents face limitations due to widespread resistance.
• Phage therapy is emerging as a promising alternative for treating MDR infections.

Purpose of the Study:

• To review the latest advancements in phage therapy for MDR infections.
• To explore phage attack strategies, formulations, and administration routes.
• To discuss the clinical trial status, challenges, and future prospects of phage therapy.

Main Methods:

• Literature review of in vitro and in vivo studies on phage therapy.
• Analysis of current clinical trial data for phage therapy applications.
• Synthesis of information on phage mechanisms, delivery, and regulatory hurdles.

Main Results:

• Phage therapy demonstrates significant bactericidal and anti-biofilm activity against MDR bacteria.
• Various phage formulations and administration routes are being investigated for efficacy and safety.
• Several phage therapy candidates are progressing through clinical trials for diverse infections.

Conclusions:

• Phage therapy shows considerable potential as a safe and effective treatment for MDR infections.
• Overcoming challenges in phage therapy development and clinical implementation is crucial for its widespread adoption.
• Continued research and clinical evaluation are essential to fully realize the therapeutic promise of bacteriophages.